MIA Antikörper (C-Term)
Kurzübersicht für MIA Antikörper (C-Term) (ABIN7180201)
Target
Alle MIA Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- C-Term
-
Kreuzreaktivität
- Human, Maus
-
Aufreinigung
- The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
-
Immunogen
- Synthesized peptide derived from C-terminal of Human MIA.
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- IHC:1:50-1:100,
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- Rabbit IgG in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150 mM NaCl, 0.02 % sodium azide and 50 % glycerol.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C,-80 °C
-
Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- MIA (Melanoma Inhibitory Activity (MIA))
-
Andere Bezeichnung
- MIA
-
Hintergrund
-
Background: Elicits growth inhibition on melanoma cells in vitro as well as some other neuroectodermal tumors, including gliomas.
Blesch A., Cancer Res. 54:5695-5701(1994).
Bosserhoff.,J. Biol. Chem. 271:490-495(1996).Aliases: Cartilage derived retinoic acid sensitive protein antibody, CD RAP antibody, CDRAP antibody, Melanoma derived growth regulatory protein precursor antibody, Melanoma inhibitory activity protein antibody, Melanoma-derived growth regulatory protein antibody, Mia antibody, MIA_HUMAN antibody
-
UniProt
- Q16674
Target
-